NEALS 30-Year Impact Report
The NEALS 30-Year Impact Report reflects three decades of advancement in ALS clinical research and the collaboration that has shaped the field. It highlights key milestones, scientific contributions, and the collective efforts of investigators, study teams, people living with ALS, caregivers, industry partners, and advocates across NEALS.
Now Accepting Applications:
2026 ALS Clinical Research Learning Institute® (CRLI)
Applications are now open for the 2026 ALS Clinical Research Learning Institute® (CRLI), hosted by the Network of Excellence for ALS (NEALS).
Our Mission
Our mission is to accelerate the development of new treatments through innovative research and working collaboratively with people living with ALS and all stakeholders in the ALS research community.
Search Trials
With support from The ALS Association, NEALS provides up-to-date information for finding both federally and privately funded clinical studies focusing on ALS and MND.
Contact an ALS Specialist
NEALS wants to make it easy for you to connect with a specialist. Use our search feature to find contact information for specialists in over 140 locations across the country and abroad.
Educational Webinars
Trials News & Events
New ALS drug stabilizes decline with a trend toward improved strength, mobility for some
Long-term use of tofersen slows ALS disease progression in people with a genetic subtype, provides hope for treating other forms of ALS.
NeurologyLive® Mind Moments®podcast Episode 154: NEALS 2025: Takeaways That Matter for ALS Care
The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.